BIOLASE Inc Share Price Nasdaq
Equities
US0909111082
Advanced Medical Equipment & Technology
Sales 2024 * | 51.5M 4.3B | Sales 2025 * | 55.5M 4.63B | Capitalization | 5.04M 420M |
---|---|---|---|---|---|
Net income 2024 * | -8M -668M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | 0.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-1.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.67% |
Latest transcript on BIOLASE Inc
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 01/17/01 |
Director of Finance/CFO | 53 | 01/21/01 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 01/14/01 |
John Beaver
CEO | Chief Executive Officer | 62 | 01/17/01 |
Director/Board Member | 73 | 16/21/16 |
1st Jan change | Capi. | |
---|---|---|
+7.73% | 220B | |
+6.10% | 183B | |
+10.56% | 133B | |
+24.39% | 107B | |
-0.95% | 63.05B | |
+11.23% | 51.74B | |
+4.81% | 50.47B | |
-1.06% | 40.91B | |
+24.14% | 31.91B |